Enhanced depth imaging optical coherence tomography in age-related macular degeneration

Seminars in Ophthalmology

Volumn 27, Issue 5-6, 2012, Pages 209-212

  Skondra, Dimitra ^a   Papakostas, Thanos ^a   Vavvas, Demetrios G ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

AMD; Choroidal thickness; Imaging

Indexed keywords

RANIBIZUMAB;

B SCAN; DRY RETINA MACULA AGE RELATED DEGENERATION; ENHANCED DEPTH IMAGING OPTICAL COHERENCE TOMOGRAPHY; EXUDATIVE MACULAR DEGENERATION; HUMAN; MACHINE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA DEGENERATION; REVIEW; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; CHOROID; GEOGRAPHIC ATROPHY; ORGAN SIZE; PATHOLOGY;

CHOROID; GEOGRAPHIC ATROPHY; HUMANS; ORGAN SIZE; TOMOGRAPHY, OPTICAL COHERENCE; WET MACULAR DEGENERATION;

EID: 84869758764     PISSN: 08820538     EISSN: 17445205     Source Type: Journal    
DOI: 10.3109/08820538.2012.708807     Document Type: Review

References (27)

1. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254:1178-1181. (Pubitemid 21917444)
2. Hee MR, Izatt JA, Swanson EA, et al. Optical coherence tomography of the human retina. Arch Ophthalmol. 1995;113:325-332.
3. Puliafito CA, Hee MR, Lin CP, et al. Imaging of macular diseases with optical coherence tomography. Ophthalmology. 1995;102:217-229.
4. Hee MR, Puliafito CA, Wong C, et al. Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol. 1995;113:1019-1029.
5. Massin P, Girach A, Erginay A, Gaudric A. Optical coherence tomography: A key to the future management of patients with diabetic macular oedema. Acta Ophthalmol Scand. 2006;84;466-474. (Pubitemid 44109046)
6. Panozzo G, Gusson E, Parolini B, Mercanti A. Role of OCT in the diagnosis and follow-up of diabetic macular edema. Semin Ophthalmol. 2003;18:74-81. (Pubitemid 37108396)
7. An L, Wang RK. Use of a scanner to modulate spatial interferograms for in vivo full-range Fourier-domain optical coherence tomography. Opt Lett. 2007;32:3423-3425. (Pubitemid 351328361)
8. Wang RK. Fourier-domain optical coherence tomography achieves full range complex imaging in vivo by introducing a carrier frequency during scanning. Phys Med Biol. 2007;52:5897-5907. (Pubitemid 47485420)
9. Vakoc BJ, Yun SH, Tearney GJ, Bouma BE. Elimination of depth degeneracy in optical frequency-domain imaging through polarization-based optical demodulation. Opt Lett. 2006;31:362-364.
10. Spaide RF, Koizumi H, Pozonni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008;146:496-500.
11. Rahman W, Chen FK, Yeoh J, Patel P, Tufail A, Da Cruz L. Repeatability of manual subfoveal choroidal thickness measurements in healthy subjects using the technique of enhanced depth imaging optical coherence tomography. Invest Ophthalmol Vis Sci. 2011 Apr 8;52(5):2267-71.
12. Chhablani J, Barteselli G, Wang H, El-Emam S, Kozak I, Doede AL, Bartsch DU, Cheng L, Freeman WR. Repeatability and reproducibility of manual choroidal volume measurements using enhanced depth imaging optical coherence tomography. Invest Ophthalmol Vis Sci. 2012 Apr 24;53(4):2274-80.
13. Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol. 2009;147:811-815.
14. Ramrattan RS, van der Schaft TL, Mooy CM, de Bruijn WC, Mulder PG, de Jong PT. Morphometric analysis of Bruch's membrane, the choriocapillaris, and the choroid in aging. Invest Ophthalmol Vis Sci. 1994;35:2857-2864. (Pubitemid 24149800)
15. Manjunath V, Taha M, Fujimoto JG, Duker JS. Choroidal thickness in normal eyes measured using Cirrus HD optical coherence tomography. Am J Ophthalmol. 2010;150:325-329.
16. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology 1992; 99:933-943.
17. Fung AE, Lalwani GA, Rosenfeld PJ, et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 2007;143:566-583.
18. Switzer DW Jr, Mendonça LS, Saito M, Zweifel SA, Spaide RF. Segregation of ophthalmoscopic characteristics according to choroidal thickness in patients with early age related macular. Retina. 2012 Jul;32(7):1265-1271.
19. Spaide RF, Curcio CA. Anatomic correlates to the bands seen in the outer retina by optical coherence tomography: Literature review and model. Retina 2011;31:1609-1619.
20. Zweifel SA, Spaide RF, Curcio CA, et al. Reticular pseudodrusen are subretinal drusenoid deposits. Ophthalmology 2010;117:303-312.e1.
21. Querques G, Querques L, Forte R, Massamba N, Coscas F, Souied EH. Choroidal changes associated with reticular pseudodrusen. Invest Ophthalmol Vis Sci. 2012 Mar 9;53(3):1258-63.
22. Querques G, Querques L, Martinelli D, et al. Pathologic insights from integrated imaging of reticular pseudodrusen in age-related macular degeneration. Retina. 2011;31:518-526
23. Spraul CW, Lang GE, Grossniklaus HE, Lang GK. Histologic and morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in postmortem eyes with age-related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes. Surv Ophthalmol 1999;44:S10-S32.
24. Yamazaki T, Koizumi H, Yamagishi T, Kinoshita S. Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month results. Ophthalmology. 2012 Aug;119(8):1621-1627.
25. Koizumi H, Yamagishi T, Yamazaki T, Kawasaki R, Kinoshita S. Subfoveal choroidal thickness in typical age-related macular degeneration and polypodal chroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol. 2011 Aug;249(8):1123-8.
26. Chung SE, Kang SW, Lee JH, Kim YT. Choroidal changes in thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Ophthalmology. 2011 May;118(5):840-5.
27. Maruko I, Iida T, Sugano Y, Saito M, Sekiryu T. Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol. 2011 Apr;151(4):594-603.e1.